Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,784 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

NCT04576455

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Northwest Georgia Oncology Centers PC - Marietta Marietta, Georgia, United States
  • University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Northwest Cancer Specialists - Portland (SW Barnes Rd) Tigard, Oregon, United States
  • Instituto Angel Roffo Buenos Aires, Argentina
View all 81 locations
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT04961996

Conditions
Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations
  • Southern Cancer Center Daphne, Alabama, United States
  • CBCC Global Research Inc., at Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • St Joseph Heritage Healthcare Fullerton, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
View all 622 locations
View Trial Details
Active, not recruiting

A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer

NCT01791829

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer Agency, Centre for the North Prince George, British Columbia, Canada
  • BCCA - Vancouver Centre Vancouver, British Columbia, Canada
View all 27 locations
View Trial Details
Active, not recruiting

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

NCT04837209

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, not recruiting

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

NCT04298086

Conditions
Body Weight, Breast Cancer, Breast Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

NCT05306340

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC-CASA Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
View all 136 locations
View Trial Details

Related conditions